Abstract

Objective

To examine the cost-effectiveness of a preventive self-care health management program for community-dwelling older adults as compared to usual care.

Design/Intervention

A cost-effectiveness analysis was executed alongside a randomised controlled trial. Nurse case managers provided interventions, including holistic assessment, empowerment of self-care, preventive health behaviours and self-efficacy with co-produced care planning, supported by nursing students. The control group received social control calls.

Participants/Setting

Community-dwelling older adults were randomly assigned to the intervention (n = 271) or control (n = 269) group. The intervention was conducted in collaboration with 11 community centres under four non-government organisations in various districts of Hong Kong.

Measurements

Cost and quality-adjusted life years (QALYs) were collected pre (baseline, 0 months) and post intervention (3 months) and 3 months after completion of the program (6 months). Incremental cost-effectiveness ratios between the groups were calculated, dividing the difference in cost by the difference in QALYs.

Results

Analysis showed that the net incremental QALY gain was 0.0014 (3 months) and 0.0033 (6 months) when the intervention group was compared to the control group. The probability of being cost-effective at 6 months was 53.2% and 53.4%, based on the cost-effectiveness thresholds recommended by both the National Institute for Health and Clinical Excellence ($200,000/QALYs) and the World Health Organization (Hong Kong gross domestic product/capita, HK$381,780).

Conclusions

The results provide some evidence to suggest that the addition of a home-based, preventive self-care health management program may have effects on cost outcomes for community-dwelling older adults in Hong Kong.

Key points

  • The increasing aging population poses a formidable challenge to policymakers needing to implement cost-effective programs.

  • This study shows that the implementation of a preventive self-care program has a medium chance of being cost-effective.

  • Future studies can draw on these findings and increase the follow-up period to assess costs and health effects.

Introduction

Many countries have placed considerable emphasis on programs that empower older adults to self-care or take control of their own health with the aim of promoting their independent living and reducing the demands they place on costly tertiary care services [1,2]. In general, these programs cover a wide range of interacting activities, such as nurse-led home visitation, health promotion and education, and case management and coordination. Evidence on the effects of health outcomes on these preventive programs is mixed. Though some studies reported non-positive outcomes [2,3], these preventive, integrated care programs were useful in improving physical and mental wellbeing and reducing depression and mortality rates for community-dwelling older adults [4,5]. Our current randomised control trial has also provided evidence that a nurse case management with self-care empowerment approach could produce positive health outcomes in regard to the improvement in self-efficacy, activity of daily living and quality of life amongst community-dwelling older adults [6]. The cost-effectiveness of these health maintenance programs is yet to be established, however.

Previous studies have demonstrated cost-effectiveness of preventive, self-management program on frail older adults [7–9] and older adults who have a known underlying chronic illness such as hypertension [10] and chronic obstructive pulmonary disease [11]. However, existing economic evaluation does not provide a sufficient knowledge base for addressing merely the effects of preventive self-care health management program on older adults who are functioning well and living independently in the community. In reality, these relatively healthy older adults comprise more than 80% of older people in the community [12]. Literature indicated that these functionally independent older adults who have no acute illnesses often face health and social challenges, such as difficulty in managing chronic conditions and poor knowledge of available community resources, which may lead to deterioration in their health condition and frequent use of health care services [13]. Given that these community-dwelling older adults require considerable healthcare expenditure potentially, there is a need for researchers and policy makers to identify intervention strategies that can enhance their well-being, prevent inappropriate use of healthcare services and thus control healthcare costs [14].

Methods

Design

This study was a single-blinded, randomised controlled trial, details of which have been reported elsewhere [15]. Briefly, the study was conducted in collaboration with 11 community centres under four non-government organisations in Hong Kong.

The subject inclusion criteria were (1) being aged 60 or over, (2) living within the respective service areas and (3) being cognitively competent (score ≥ 18) based on the Chinese version of the Mini-Mental Status Examination [16]. Exclusion criteria were (1) not able to communicate, (2) bedbound, (3) not able to be reached by phone, (4) not living at home, (5) having known active psychiatric problems and recent hospitalisation within the previous 6 months, (6) being already engaged in structured health or social programs and (7) not intending to stay in Hong Kong over the subsequent 3 months. Ethical approval was sought from the study university. Consent forms were signed by those subjects who met the criteria and agreed to participate in the study.

Intervention

The older adults in the intervention group received a preventive self-care health management program delivered by nurse case managers who were experienced in primary health care and trained specifically for this study. The aim of the intervention program was to engage and empower the community-dwelling older adults to take action on preventing diseases, maintaining and promoting health and functioning, and managing chronic illnesses and disabilities by assessing and resolving their health and social problems proactively, building up their self-care confidence and providing referral services to other health care disciplines in the community. The Omaha system was adopted to assist nurse case managers in conducting the holistic assessment-intervention-evaluation in the first home visit. Home visits and telephone calls were employed to follow-up on the caring goals set by the nurse case manager and older adults. The Omaha system has been validated and used in previous nurse-led self-care studies [17,18]. Appendix 1 shows the study flow of the program.

Older adults in the control group received monthly social control calls from another group of student helpers to exclude any possible social effects of the intervention. As in routine practices, they could voluntarily join the episodic, unstructured health and social services organised by their respective community centres. For details of the interventions, see the published protocol [15].

Study procedure and data collection

A three-month intervention program was introduced in this study, with the first month acting as a loading dose that involved weekly intervention contact. The second and third months were considered as maintenance dose, with biweekly intervention contact. Cost and health outcomes were collected pre (baseline, 0 months) and post intervention (3 months) and 3 months after completion of the program (6 months) by research assistants who were not involved in the program.

Cost and health outcomes

The costing was estimated from the healthcare provider’s perspective. The cost components included the pre-intervention training, the intervention cost for the service provider and the health service cost related to medical consultation and hospital admissions. The pre-intervention training cost was the time cost for both the trainers and the trainees. It was calculated by multiplying the total time spent on training with the salary of the corresponding staff rank (Appendix 2). The median monthly salary of Hong Kong (2016 rate adjusted to 2018 level using CPI) was used to estimate the time cost for nursing students. The service provider cost for delivering the intervention included the staff time spent on home visits, telephone calls and documentation, as well as the equipment purchased for the study. Health service costs included all public and private health services the subjects used during the study period, i.e. between baseline and 6 months. They were calculated as the number of visits multiplied by the unit costs for each type of service based on the HA’s latest public charges to non-eligible persons [19], i.e. GP visits (HK$445), emergency (A&E) admissions (HK$1,230) and in-patient admissions ($5,100 per bed day). We multiplied the number of in-patient admissions with the median length of stay in hospital (3 days) to estimate the total hospitalisation cost. The actual length of stay in hospital was not used when estimating the cost in the main analysis to avoid the extreme values from long-stay patients, but we used it as an alternative scenario in the sensitivity analysis. For the control group, we used the same approach as described above to estimate the cost of training, the staff’s time spent on social calls and the health service costs. All costs were based on year 2018 rates.

Quality-adjusted life years (QALYs) were used as one of the health outcomes of the intervention. Quality of life (QOL) data were collected using the Hong Kong Chinese version of the 12-item Short-Form Health Survey (SF-12 HK). The QOL data were translated into a health utility score based on an algorithm derived from the local population [20]. The QALYs gained at 3 and 6 months were then calculated by multiplying the utility score by the length of time the subject spent in that health state, i.e. the area under the curve. Only subjects who had completed the QOL survey at all three time points were included when comparing the QALYs gained. Other health outcomes included the number of public and private GP visits, A&E and in-patient admissions and total length of stay in hospital.

Differences between groups were compared using the Mann–Whitney U test for non-normally distributed continuous variables. The ANOVA test was used to compare the QOL between groups and over different time points. Any significant differences in health service utilisation were used to estimate the number of patients needed to be treated by the intervention in order to prevent one GP visit or in-patient admission i.e. NNT = 1/(event rate in control group—event rate in intervention group). The missing data were imputed using multiple imputation by chained equation.

Cost-effectiveness analyses

Incremental cost-effectiveness ratios (ICERs) between the groups were calculated by dividing the difference in total cost by the difference in QALYs. The ICERs were compared with the willingness to pay (WTP) threshold for a QALY, which was equal to (a) £20,000/QALY (approximately HK$200,000, £1 = HK$10) as suggested by the NICE guideline [21] and (b) year 2018 gross domestic product (GDP) per capita in Hong Kong (HK$381,870) based on the WHO guideline, which suggested that ICERs of less than 1 to 2 times per capita GDP could be considered cost-effective [22]. Sensitivity analyses were conducted to capture the uncertainties around the cost-effectiveness parameters. One-way sensitivity analysis was performed by testing with a 30% variation higher/lower in program costs and a range of the 95% confidence interval (CIs) for health service utilisation (due to GP visits and in-patient admissions). We also included three scenario analyses to test 1) a wider range of costs by including the subject time spent on home visits and telephone calls, 2) applied actual length of stay in hospital for cost estimation and 3) conducted multiple imputation using chained equation based on other data including demographical and disease history to replace the missing values in health service utilisation and QOL data. The probabilistic sensitivity analyses recalculated the ICER 10,000 times, selecting random values for program cost, health service utilisation and health utility in each iteration. Program cost varied within +/−30% of training and intervention cost by using uniform distribution. The health service utilisation and values for health utility varied based on a bootstrapping method, selecting random values from the intervention and control groups, respectively.

Results

Of the 926 potential community-dwelling older adults who were assessed for eligibility, 540 participants agreed to join the program and were randomised into intervention (n = 271) or control groups (n = 269). At the 6-month follow-up, 41 and 40 participants were lost to follow-up in the respective intervention and control groups due to death, admission to care homes and data collection refusal (Appendix 1). The number of public and private GP visits, A&E admissions and in-patient admissions was lower in the intervention group. The differences were statistically significant for the number of public GP visits at 3 months and 6 months, private GP visits at 6 months and length of stay in hospital at 3 months (Table 1). In terms of number needed to treat (NNT), the intervention needed to treat seven subjects to remove one public GP visit and four subjects to remove one private GP visits in 6 months. Both the intervention and control groups showed a significant increase in QOL from the baseline. The estimated QALY gains of the intervention group for 3 and 6 months were 0.0014 and 0.0033, respectively.

Table 1

Comparison of health outcomes at different time points

Intervention group (N = 230)Control group (N = 229)P-value
Health service utilisation
Number of public GP visits, (mean, 95% CI)3 months0.11 (0.05–0.18)0.22 (0.15–0.29)0.003a
6 months0.28 (0.16–0.40)0.43 (0.32–0.54)0.004a
Number of private GP visits, (mean, 95% CI)3 months0.62 (0.47–0.77)0.73 (0.58–0.88)0.126a
6 months1.25 (1.02–1.48)1.54 (1.27–1.81)0.038a
Number of A&E admissions, (mean, 95% CI)3 months0.07 (0.04–0.11)0.10 (0.06–0.15)0.229a
6 months0.14 (0.09–0.19)0.22 (0.15–0.29)0.105a
Number of in-patient admissions, (mean, 95% CI)3 months0.07 (0.02–0.11)0.09 (0.05–0.13)0.146a
6 months0.12 (0.07–0.17)0.16 (0.11–0.21)0.253a
Total length of stay in hospital, (mean, 95% CI)3 months0.36 (0.05–0.67)0.38 (0.13–0.63)0.040a
6 months0.84 (0.22–1.46)0.76 (0.27–1.25)0.129a
Health utility
QOL score, (mean, 95% CI)Baseline0.713 (0.692–0.735)0.702 (0.680–0.725)0.386b
3 months0.769 (0.750–0.789)0.747 (0.726–0.767)0.130b
6 months0.785 (0.767–0.803)0.771 (0.752–0.790)0.396b
Within-group comparison (P-value)<0.001c<0.001c
QALY gained from baseline, (mean, 95% CI)3 months0.0070 (0.0043–0.0097)0.0056 (0.0030–0.0082)0.239a
6 months0.0252 (0.0171–0.0333)0.0219 (0.0141–0.0297)0.380a
Intervention group (N = 230)Control group (N = 229)P-value
Health service utilisation
Number of public GP visits, (mean, 95% CI)3 months0.11 (0.05–0.18)0.22 (0.15–0.29)0.003a
6 months0.28 (0.16–0.40)0.43 (0.32–0.54)0.004a
Number of private GP visits, (mean, 95% CI)3 months0.62 (0.47–0.77)0.73 (0.58–0.88)0.126a
6 months1.25 (1.02–1.48)1.54 (1.27–1.81)0.038a
Number of A&E admissions, (mean, 95% CI)3 months0.07 (0.04–0.11)0.10 (0.06–0.15)0.229a
6 months0.14 (0.09–0.19)0.22 (0.15–0.29)0.105a
Number of in-patient admissions, (mean, 95% CI)3 months0.07 (0.02–0.11)0.09 (0.05–0.13)0.146a
6 months0.12 (0.07–0.17)0.16 (0.11–0.21)0.253a
Total length of stay in hospital, (mean, 95% CI)3 months0.36 (0.05–0.67)0.38 (0.13–0.63)0.040a
6 months0.84 (0.22–1.46)0.76 (0.27–1.25)0.129a
Health utility
QOL score, (mean, 95% CI)Baseline0.713 (0.692–0.735)0.702 (0.680–0.725)0.386b
3 months0.769 (0.750–0.789)0.747 (0.726–0.767)0.130b
6 months0.785 (0.767–0.803)0.771 (0.752–0.790)0.396b
Within-group comparison (P-value)<0.001c<0.001c
QALY gained from baseline, (mean, 95% CI)3 months0.0070 (0.0043–0.0097)0.0056 (0.0030–0.0082)0.239a
6 months0.0252 (0.0171–0.0333)0.0219 (0.0141–0.0297)0.380a

aMann–Whitney U test,

bANOVA test (comparing between groups at 3 and 6 months, adjusted with baseline),

cRepeated measures ANOVA.

Table 1

Comparison of health outcomes at different time points

Intervention group (N = 230)Control group (N = 229)P-value
Health service utilisation
Number of public GP visits, (mean, 95% CI)3 months0.11 (0.05–0.18)0.22 (0.15–0.29)0.003a
6 months0.28 (0.16–0.40)0.43 (0.32–0.54)0.004a
Number of private GP visits, (mean, 95% CI)3 months0.62 (0.47–0.77)0.73 (0.58–0.88)0.126a
6 months1.25 (1.02–1.48)1.54 (1.27–1.81)0.038a
Number of A&E admissions, (mean, 95% CI)3 months0.07 (0.04–0.11)0.10 (0.06–0.15)0.229a
6 months0.14 (0.09–0.19)0.22 (0.15–0.29)0.105a
Number of in-patient admissions, (mean, 95% CI)3 months0.07 (0.02–0.11)0.09 (0.05–0.13)0.146a
6 months0.12 (0.07–0.17)0.16 (0.11–0.21)0.253a
Total length of stay in hospital, (mean, 95% CI)3 months0.36 (0.05–0.67)0.38 (0.13–0.63)0.040a
6 months0.84 (0.22–1.46)0.76 (0.27–1.25)0.129a
Health utility
QOL score, (mean, 95% CI)Baseline0.713 (0.692–0.735)0.702 (0.680–0.725)0.386b
3 months0.769 (0.750–0.789)0.747 (0.726–0.767)0.130b
6 months0.785 (0.767–0.803)0.771 (0.752–0.790)0.396b
Within-group comparison (P-value)<0.001c<0.001c
QALY gained from baseline, (mean, 95% CI)3 months0.0070 (0.0043–0.0097)0.0056 (0.0030–0.0082)0.239a
6 months0.0252 (0.0171–0.0333)0.0219 (0.0141–0.0297)0.380a
Intervention group (N = 230)Control group (N = 229)P-value
Health service utilisation
Number of public GP visits, (mean, 95% CI)3 months0.11 (0.05–0.18)0.22 (0.15–0.29)0.003a
6 months0.28 (0.16–0.40)0.43 (0.32–0.54)0.004a
Number of private GP visits, (mean, 95% CI)3 months0.62 (0.47–0.77)0.73 (0.58–0.88)0.126a
6 months1.25 (1.02–1.48)1.54 (1.27–1.81)0.038a
Number of A&E admissions, (mean, 95% CI)3 months0.07 (0.04–0.11)0.10 (0.06–0.15)0.229a
6 months0.14 (0.09–0.19)0.22 (0.15–0.29)0.105a
Number of in-patient admissions, (mean, 95% CI)3 months0.07 (0.02–0.11)0.09 (0.05–0.13)0.146a
6 months0.12 (0.07–0.17)0.16 (0.11–0.21)0.253a
Total length of stay in hospital, (mean, 95% CI)3 months0.36 (0.05–0.67)0.38 (0.13–0.63)0.040a
6 months0.84 (0.22–1.46)0.76 (0.27–1.25)0.129a
Health utility
QOL score, (mean, 95% CI)Baseline0.713 (0.692–0.735)0.702 (0.680–0.725)0.386b
3 months0.769 (0.750–0.789)0.747 (0.726–0.767)0.130b
6 months0.785 (0.767–0.803)0.771 (0.752–0.790)0.396b
Within-group comparison (P-value)<0.001c<0.001c
QALY gained from baseline, (mean, 95% CI)3 months0.0070 (0.0043–0.0097)0.0056 (0.0030–0.0082)0.239a
6 months0.0252 (0.0171–0.0333)0.0219 (0.0141–0.0297)0.380a

aMann–Whitney U test,

bANOVA test (comparing between groups at 3 and 6 months, adjusted with baseline),

cRepeated measures ANOVA.

The costs for the program and health service are shown in Table 2. The intervention group had higher program costs but lower health service costs at both time points. The total costs per subject for the intervention group were $2,678 and $3,979 for 3 and 6 months, respectively, whilst the equivalent costs for the control group were $2,021 and $3,623, respectively. The incremental cost per subject for the intervention was $657 for 3 months and $356 for 6 months.

Table 2

Cost of program and health service by group

Intervention group (N = 230)Control group (N = 229)
NHourly costTotal costNHourly costTotal cost
Pre-program training
  Trainee (nurse)2$255$1,018
  Trainee (student helper)22$99$6,00613$99$323
  Trainer$11,154$745
Program costTime (min)Hourly costTotal costTime (min)Hourly costTotal cost
 Intervention
  Nurse case manager103$255$100,517
  Student helper102$99$38,81523$99$8,714
 Administration/documentation
  Nurse case manager20$255$19,518
  Student helper20$99$7,61115$99$5,683
 Travel time costs (home visit)
  Nurse case manager60$255$58,553
  Student helper60$99$22,832
Equipment cost$24,376
Total program cost per subject$1,263$68
Subject time cost*205$99$78,01023$99$8,714
Total program cost per subject (included subject time)$1,602$106
Health service costMeanUnit costTotal CostMeanUnit costTotal Cost
 Public GP visits
  3 months0.11$445$11,5700.22$445$22,250
  6 months0.28$445$28,9250.43$445$44,055
 Private GP visits
  3 months0.62$445$63,6350.73$445$74,315
  6 months1.25$445$128,1601.54$445$156,640
 Emergency admissions
  3 months0.07$1,230$20,9100.10$1,230$29,520
  6 months0.14$1,230$39,3600.22$1,230$62,730
 In-patient admissions
  3 months0.20$5,100$229,5000.28$5,100$321,300
  6 months0.37$5,100$428,4000.47$5,100$550,800
Total cost per subject (program cost without subject time + health service)
  3 months$2,678$2,021
  6 months$3,979$3,623
Intervention group (N = 230)Control group (N = 229)
NHourly costTotal costNHourly costTotal cost
Pre-program training
  Trainee (nurse)2$255$1,018
  Trainee (student helper)22$99$6,00613$99$323
  Trainer$11,154$745
Program costTime (min)Hourly costTotal costTime (min)Hourly costTotal cost
 Intervention
  Nurse case manager103$255$100,517
  Student helper102$99$38,81523$99$8,714
 Administration/documentation
  Nurse case manager20$255$19,518
  Student helper20$99$7,61115$99$5,683
 Travel time costs (home visit)
  Nurse case manager60$255$58,553
  Student helper60$99$22,832
Equipment cost$24,376
Total program cost per subject$1,263$68
Subject time cost*205$99$78,01023$99$8,714
Total program cost per subject (included subject time)$1,602$106
Health service costMeanUnit costTotal CostMeanUnit costTotal Cost
 Public GP visits
  3 months0.11$445$11,5700.22$445$22,250
  6 months0.28$445$28,9250.43$445$44,055
 Private GP visits
  3 months0.62$445$63,6350.73$445$74,315
  6 months1.25$445$128,1601.54$445$156,640
 Emergency admissions
  3 months0.07$1,230$20,9100.10$1,230$29,520
  6 months0.14$1,230$39,3600.22$1,230$62,730
 In-patient admissions
  3 months0.20$5,100$229,5000.28$5,100$321,300
  6 months0.37$5,100$428,4000.47$5,100$550,800
Total cost per subject (program cost without subject time + health service)
  3 months$2,678$2,021
  6 months$3,979$3,623

*Included in sensitivity analysis only

Table 2

Cost of program and health service by group

Intervention group (N = 230)Control group (N = 229)
NHourly costTotal costNHourly costTotal cost
Pre-program training
  Trainee (nurse)2$255$1,018
  Trainee (student helper)22$99$6,00613$99$323
  Trainer$11,154$745
Program costTime (min)Hourly costTotal costTime (min)Hourly costTotal cost
 Intervention
  Nurse case manager103$255$100,517
  Student helper102$99$38,81523$99$8,714
 Administration/documentation
  Nurse case manager20$255$19,518
  Student helper20$99$7,61115$99$5,683
 Travel time costs (home visit)
  Nurse case manager60$255$58,553
  Student helper60$99$22,832
Equipment cost$24,376
Total program cost per subject$1,263$68
Subject time cost*205$99$78,01023$99$8,714
Total program cost per subject (included subject time)$1,602$106
Health service costMeanUnit costTotal CostMeanUnit costTotal Cost
 Public GP visits
  3 months0.11$445$11,5700.22$445$22,250
  6 months0.28$445$28,9250.43$445$44,055
 Private GP visits
  3 months0.62$445$63,6350.73$445$74,315
  6 months1.25$445$128,1601.54$445$156,640
 Emergency admissions
  3 months0.07$1,230$20,9100.10$1,230$29,520
  6 months0.14$1,230$39,3600.22$1,230$62,730
 In-patient admissions
  3 months0.20$5,100$229,5000.28$5,100$321,300
  6 months0.37$5,100$428,4000.47$5,100$550,800
Total cost per subject (program cost without subject time + health service)
  3 months$2,678$2,021
  6 months$3,979$3,623
Intervention group (N = 230)Control group (N = 229)
NHourly costTotal costNHourly costTotal cost
Pre-program training
  Trainee (nurse)2$255$1,018
  Trainee (student helper)22$99$6,00613$99$323
  Trainer$11,154$745
Program costTime (min)Hourly costTotal costTime (min)Hourly costTotal cost
 Intervention
  Nurse case manager103$255$100,517
  Student helper102$99$38,81523$99$8,714
 Administration/documentation
  Nurse case manager20$255$19,518
  Student helper20$99$7,61115$99$5,683
 Travel time costs (home visit)
  Nurse case manager60$255$58,553
  Student helper60$99$22,832
Equipment cost$24,376
Total program cost per subject$1,263$68
Subject time cost*205$99$78,01023$99$8,714
Total program cost per subject (included subject time)$1,602$106
Health service costMeanUnit costTotal CostMeanUnit costTotal Cost
 Public GP visits
  3 months0.11$445$11,5700.22$445$22,250
  6 months0.28$445$28,9250.43$445$44,055
 Private GP visits
  3 months0.62$445$63,6350.73$445$74,315
  6 months1.25$445$128,1601.54$445$156,640
 Emergency admissions
  3 months0.07$1,230$20,9100.10$1,230$29,520
  6 months0.14$1,230$39,3600.22$1,230$62,730
 In-patient admissions
  3 months0.20$5,100$229,5000.28$5,100$321,300
  6 months0.37$5,100$428,4000.47$5,100$550,800
Total cost per subject (program cost without subject time + health service)
  3 months$2,678$2,021
  6 months$3,979$3,623

*Included in sensitivity analysis only

The intervention group had made some gains in QALYs. The ICER of the program was HK$456,018 for 3 months and $109,453 for 6 months (Table 3). One-way sensitivity analysis showed that the ICERs ranged from $207,226 to $704,811 for 3 months and from $-366,649 to $401,544 for 6 months. The results showed that the program can be cost-effective at 6 months when compared to one GDP per capita (HK$381,780) according to the WHO guideline but may be less promising using the NICE thresholds. The scenario with imputed missing values showed a possibility of being cost saving; however, the estimates could be biased as the varied value of imputed health service utilisation indicated that it may not be accurately predicted by the other observed data. Figures 1 and 2 show the results of the probabilistic sensitivity analyses. The cost-effectiveness plane showed that the probability of the program being cost-saving, i.e. in the south-eastern quadrant, was 6.4% and 12.0% for 3 and 6 months, respectively. The acceptability curve showed that the program had a 49.7% and 53.2% likelihood of being cost-effective for 3 and 6 months respectively when considering the NICE threshold of $200,000, and it had a 52.2% and 53.4% likelihood of being cost-effective for 3 and 6 months, respectively, when compared to one GDP per capita (HK$381,780) in Hong Kong.

Table 3

Main results and one-way sensitivity analyses of cost-effectiveness analysis

3 months6 months
Incremental cost (HK$)QALYs gainedICER (HK$)Incremental cost (HK$)QALYs gainedICER (HK$)
Base6570.0014456,0183560.0033109,453
Intervention cost
 30% lower2990.0014207,226-20.0033-706
 30% higher1,0160.0014704,8117150.0033219,613
Health service utilisation
 95% CI minimum6580.0014456,6264400.0033135,189
 95% CI maximum6560.0014455,4102720.003383,719
QOL score
 95% CI minimum6570.0014470,6583560.0031115,492
 95% CI maximum6570.0015442,2543560.0034104,014
Scenario—Included subjects’ time cost9580.0014664,9776570.0033201,976
Scenario—Actual length of stay9600.0014666,4421,3070.0033401,544
Scenario—Imputed missing values5300.0016334,503-1,2370.0034-366,649
3 months6 months
Incremental cost (HK$)QALYs gainedICER (HK$)Incremental cost (HK$)QALYs gainedICER (HK$)
Base6570.0014456,0183560.0033109,453
Intervention cost
 30% lower2990.0014207,226-20.0033-706
 30% higher1,0160.0014704,8117150.0033219,613
Health service utilisation
 95% CI minimum6580.0014456,6264400.0033135,189
 95% CI maximum6560.0014455,4102720.003383,719
QOL score
 95% CI minimum6570.0014470,6583560.0031115,492
 95% CI maximum6570.0015442,2543560.0034104,014
Scenario—Included subjects’ time cost9580.0014664,9776570.0033201,976
Scenario—Actual length of stay9600.0014666,4421,3070.0033401,544
Scenario—Imputed missing values5300.0016334,503-1,2370.0034-366,649
Table 3

Main results and one-way sensitivity analyses of cost-effectiveness analysis

3 months6 months
Incremental cost (HK$)QALYs gainedICER (HK$)Incremental cost (HK$)QALYs gainedICER (HK$)
Base6570.0014456,0183560.0033109,453
Intervention cost
 30% lower2990.0014207,226-20.0033-706
 30% higher1,0160.0014704,8117150.0033219,613
Health service utilisation
 95% CI minimum6580.0014456,6264400.0033135,189
 95% CI maximum6560.0014455,4102720.003383,719
QOL score
 95% CI minimum6570.0014470,6583560.0031115,492
 95% CI maximum6570.0015442,2543560.0034104,014
Scenario—Included subjects’ time cost9580.0014664,9776570.0033201,976
Scenario—Actual length of stay9600.0014666,4421,3070.0033401,544
Scenario—Imputed missing values5300.0016334,503-1,2370.0034-366,649
3 months6 months
Incremental cost (HK$)QALYs gainedICER (HK$)Incremental cost (HK$)QALYs gainedICER (HK$)
Base6570.0014456,0183560.0033109,453
Intervention cost
 30% lower2990.0014207,226-20.0033-706
 30% higher1,0160.0014704,8117150.0033219,613
Health service utilisation
 95% CI minimum6580.0014456,6264400.0033135,189
 95% CI maximum6560.0014455,4102720.003383,719
QOL score
 95% CI minimum6570.0014470,6583560.0031115,492
 95% CI maximum6570.0015442,2543560.0034104,014
Scenario—Included subjects’ time cost9580.0014664,9776570.0033201,976
Scenario—Actual length of stay9600.0014666,4421,3070.0033401,544
Scenario—Imputed missing values5300.0016334,503-1,2370.0034-366,649
Cost-effectiveness plane.
Figure 1

Cost-effectiveness plane.

Cost-effectiveness acceptability curve.
Figure 2

Cost-effectiveness acceptability curve.

Discussion

To our knowledge, this study is one of the few to evaluate the cost-effectiveness of a preventive self-care health management program on a general population of community-dwelling older adults. The current study showed that the likelihood of being cost-effective at 6 months is greater than at 3 months, with the 6-month measure being the sustained effect of the 3-month program. Studies suggest that most health promotion and self-care interventions require extensive time and effort for providers to build a therapeutic relationship, identify self-care deficits and risk factors for institutionalisation, and maximise capacity for self-care with clients [23,24]. Even with an efficient and optimal implementation process, improvements in self-care self-efficacy and changes in preventive health behaviours take time for older adults to develop [25]. Self-care is a complicated process and requires confidence, continuous support and practice. It is not a one-off event that can be triggered by information alone [26]. The findings of a systematic review revealed that most preventive self-care programs demonstrated favourable long-term outcomes, including improving self-efficacy and physical functioning, when a longer follow-up period such as 2–3 years was included [25–29]. It is expected that the longer follow-up period may have resulted in more positive effects, as proactive care may pan out more profoundly in the long run.

It should be noted that though findings of the current analysis have suggested that a preventive self-care health management program is cost-effective, it does not mean that it is affordable. Affordability is associated with household income, whether the intervention is covered by insurance and if there is public funding allocated to support and sustain the program [30]. Results of this study provide evidence to argue for a preventive health program that is cost-effective, but the payment approach needs further deliberation.

There are limitations to this study. The analysis did not include the costs of informal care, since we did not have information on the time relatives and friends spent on caring for the older adults. The community resources and services that the older adults were receiving, such as meals-on-wheels, health talks and counselling services, were also not counted in determining the total costs.

Conclusions and implications

With the emerging of ageing populations and the need to contain costs, governments and policy-makers are urged to find ways to save costs and reallocate resources to cost-effective programs that can meet the considerable health and social needs of older adults. The results of this program provided new evidence that a preventive self-care health management program delivered by nurse case managers and supported by nursing students has a potential effect on cost outcomes for community-dwelling older adults.

Declaration of Sources of Funding

This work was supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (RGC Ref No 15,604,215).

Declaration of Conflict of Interest

None.

Acknowledgements

The authors like to thank the Research Grants Council of the Hong Kong Special Administrative Region, China for supporting this study. We also thank the community centres for allowing us to work closely with them as part of this project.

References

1.

Stegeman
 
I
,
Otte-Trojel
 
T
,
Costongs
 
C
,
Considine
 
J.
 
Healthy and Active Aging
.
Euro Health Net
 
Available from
: http://www.healthyageing.eu/sites/www.healthyageing.eu/files/resources/Healthy%20and%20Active%20Ageing.pdf (2 October 2019, date last accessed).

2.

Mountain
 
G
,
Windle
 
G
,
Hind
 
D
 et al.  
A preventative lifestyle intervention for older adults (lifestyle matters): a randomized controlled trial
.
Age Ageing
 
2012
;
46
:
627
34
.

3.

Suijker
 
JJ
,
MacNeil-Vroomen
 
JL
,
van Rijn
 
M
 et al.  
Cost-effectiveness of nurse-led multifactorial care to prevent or postpone new disabilities in community-living older people: results of a cluster randomized trial
.
PLoS One
 
2017
;
12
:
e0175272
.

4.

Markle-Reid
 
M
,
McAiney
 
C
,
Forbes
 
D
 et al.  
An interprofessional nurse-led mental health promotion intervention for older home care clients with depressive symptoms
.
BMC Geriatr
 
2014
;
14
:
62
.

5.

van het Bolscher-Niehuis
 
MJT
,
den Ouden
 
MEM
,
de Vocht
 
HM
,
Francke
 
AL
.
Effects of self-management support programmes on activities of daily living of older adults: a systematic review
.
Int J Nurs Stud
 
2016
;
61
:
230
47
.

6.

Wong
 
AKC
,
Wong
 
FKY
,
Chang
 
KK
.
Effectiveness of a community-based self-care promoting program for community-dwelling older adults: a randomized controlled trial
.
Age Aging
 
2019
;
48
:
852
8
.

7.

Drubbel
 
I
,
Neslo
 
REJ
,
Bleijenberg
 
N
 et al.  Economic evaluation of a pro-active patient centered primary care program for frail older patients: cost-effectiveness analysis alongside the U-PROFIT randomised controlled trial. In:
Drubbel
 
I
, ed.
Frailty screening in older patients in primary care using routine care data
PhD Thesis
.
Utrecht University
,
2014
.

8.

Fairhall
 
N
,
Sherrington
 
C
,
Kurrle
 
SE
 et al.  
Economic evaluation of a multifactorial, interdisciplinary intervention versus usual care to reduce frailty in frail older people
.
J Am Med Dir Assoc
 
2015
;
16
:
41
8
.

9.

Melis
 
RJ
,
Adang
 
E
,
Teerenstra
 
S
 et al.  
Cost-effectiveness of a multidisciplinary intervention model for community-dwelling frail older people
.
J Gerontol A-Biol
 
2008
;
63
:
275
82
.

10.

Hong
 
J
,
Padula
 
W
,
Hollin
 
IL
 et al.  
Care management to reduce disparities and control hypertension in primary care: a cost-effectiveness analysis
.
Med Care
 
2018
;
56
:
179
85
.

11.

Bakerly
 
ND
,
Davies
 
C
,
Dyer
 
M
,
Dhillon
 
P
.
Cost analysis of an integrated care model in the management of acute exacerbations of chronic obstructive pulmonary disease
.
Chron Respir Dis
 
2009
;
6
:
201
8
.

12.

Administration on Aging
.
A profile of older Americans
:
2016
.
Available from
: https://www.giaging.org/documents/A_Profile_of_Older_Americans_2016.pdf (14 October 2019, date last accessed).

13.

Talarska
 
D
,
Strugala
 
M
,
Szewczyczak
 
M
 et al.  
Is independence of older adults safe considering the risk of falls?
 
BMC Geriatr
 
2017
;
17
:
1
7
.

14.

Roland
 
M
,
Abel
 
G
.
Reducing emergency admissions: are we on the right track?
 
BMJ
 
2012
;
345
:
e6017
.

15.

Wong
 
KC
,
Wong
 
FKY
,
Chang
 
K
.
Health-social partnership programme for community-dwelling older adults. A research protocol for a randomized controlled trial
.
J Adv Nurs
 
2015
;
71
:
2673
85
.

16.

Tsai
 
JC
,
Chen
 
CW
,
Chu
 
H
 et al.  
Comparing the sensitivity, specificity, and predictive values of the Montreal cognitive assessment and mini-mental state examination when screening people for mild cognitive impairment and dementia in a Chinese population
.
Arch Psychiat Nurs
 
2016
;
30
:
486
91
.

17.

Wong
 
FKY
,
Yeung
 
SM
.
Effects of a 4-week transitional care programme for discharged stroke survivors in Hong Kong: a randomized controlled trial
.
Health Soc Care Community
 
2014
;
23
:
619
31
.

18.

Zhu
 
X
,
Wong
 
FKY
,
Wu
 
LH
.
Development and evaluation of a nurse-led hypertension management model in a community: a pilot randomized controlled trial
.
Int J Clin Exp Med
 
2014
;
7
:
4369
77
.

19.

Hospital Authority
.
New fees and charges of public hospital services effective as of 18 June 2017
.
Available from
: https://www.ha.org.hk/visitor/ha_visitor_index.asp?Content_ID=10045&Lang=ENG (14 October 2019, date last accessed).

20.

McGhee
 
SM
,
Brazier
 
J
,
Lam
 
CLK
 et al.  
Quality-adjusted life years: population-specific measurement of the quality component
.
Hong Kong Med J
 
2011
;
17
:
S17
21
.

21.

National Institute for Health and Clinical Excellence
.
Guide to the methods of technology appraisal
 
2013
.
Available from
: https://www.nice.org.uk/process/pmg9 (16 October 2019, date last accessed).

22.

WHO Commission on Macroeconomics and Health: investing in health for economic development
.
Report of the Commission on Macroeconomics and Health: executive summary
.
Geneva
:
World Health Organization
,
2001
.

23.

van de Wetering
 
G
,
Olde Rikkert
 
M
,
van der Wilt
 
GJ
,
Adang
 
E
.
Understanding and anticipating lag-time bias in cost-effectiveness studies: the role of time in cost-effectiveness analysis
.
Int J Technol Assess Health Care
 
2014
;
30
:
608
11
.

24.

Coleman
 
S
,
Briffa
 
NK
,
Carroll
 
G
 et al.  
A randomized controlled trial of a self-management education program for osteoarthritis of the knee delivered by health care professionals
.
Arthritis Res Ther
 
2012
;
14
:
R21
.

25.

Rubenstein
 
LZ
,
Stuck
 
AE
.
Preventive home visits for older people: defining criteria for success
.
Age Ageing
 
2001
;
30
:
107
9
.

26.

Kelly
 
MP
,
Barker
 
M
.
Why is changing health-related behavior so difficult?
 
Public Health
 
2016
;
136
:
109
16
.

27.

Wong
 
AKC
,
Wong
 
FKY
,
Yeung
 
WF
 et al.  
The effect of complex interventions on supporting program for community-dwelling older adults: a systematic review and meta-analysis
.
Age Ageing
 
2018
;
47
:
185
93
.

28.

Richard-Jones
 
S
,
Mihalopoulos
 
C
,
Heckel
 
L
,
Gunn
 
KM
,
Tan
 
M
,
Livingston
 
PM
.
An economic evaluation of a telephone outcall intervention for informal carers of cancer patients in Australia: an assessment of costs and quality-adjusted-life-years
.
Psychooncology
 
2019
;
28
:
525
32
.

29.

Blom
 
JW
,
van den Hout
 
WB
,
den Elzen
 
WPJ
 et al.  
Effectiveness and cost-effectiveness of proactive and multidisciplinary integrated care for older people with complex problems in general practice: an individual participant data meta-analysis
.
Age Ageing
 
2018
;
47
:
705
14
.

30.

Niens
 
LM
.
Affordability in health care: operationalization and applications in different contexts
 
2014
.
Available from
: https://e-pubs.nl/?epub=l.niens (16 October 2019, date last accessed).

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

Supplementary data

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.